No knowledge of this treatment, but kudos for participating in the clinical trial. You’re furthering science and contributing to future treatments. Blessings to you.
ARX517 is a PSMA targeted chemotherapy drug. It uses an antibody to find cells that have PSMA (ie, the cells that show up on a PSMA/PET scan) and then it inserts a tubulin inhibitor (a form of chemotherapy) into yhe cell. This is different from lutetium (pluvicto) which kills the cell with radiation. It’s cslled an antibidy drug conjugate (ADC) since it uses an antibody to find the cancer and it injects a chemotherapy drug into the cells. This is an important area of research today!
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.